Tag: UTOI
American College of Rheumatology, Oct. 24-29
Hormone Tx Linked to Incidence, Risk for Autoimmune Disease Postmenopause
Significant increases in risk were observed for all autoimmune diseases except Graves disease and autoimmune hepatitis
SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D
SGLT-2 inhibitors linked lower risk for autoimmune rheumatic diseases compared with sulfonylureas
AMD Risk Increases With Psoriasis
Risk for unspecified AMD lower for those treated with biologics versus topical corticosteroids alone
Digital Intervention Aids Psychological Outcomes With Inflammatory Rheumatic Diseases
Clinically significant reduction in psychological distress seen at three months with digital intervention
Antibiotics in Pregnancy, Infancy Not Linked to Autoimmune Diseases
No association seen between antibiotic exposure during pregnancy or early infancy and overall incidence of autoimmune diseases
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
Once-daily inhaled molgramostim leads to greater increase in pulmonary gas transfer than placebo
Autoimmune Diseases Linked to Digestive System Cancers
Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers
Rituximab Not Superior to Conventional Strategy for Eosinophilic Granulomatosis With Polyangiitis
Rituximab no better than glucocorticoids alone for inducing remission in patients with eosinophilic granulomatosis with polyangiitis
No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines
No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder
